Adenoviral expression of TDP-43 and FUS genes and shRNAs for protein degradation pathways in rodent motoneurons in vitro and in vivo

Neuropathology

Volumn 34, Issue 1, 2014, Pages 83-98

  Watabe, Kazuhiko ^a   Akiyama, Keiko ^a   Kawakami, Emiko ^a   Ishii, Tomohiro ^a   Endo, Kentaro ^a   Yanagisawa, Hiroko ^a   Sango, Kazunori ^a   Tsukamoto, Masami ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Autophagy; FUS; Proteasome; TDP 43

Indexed keywords

ADENOVIRUS VECTOR; FUSED IN SARCOMA PROTEIN; PROTEASOME; SHORT HAIRPIN RNA; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOPHAGY; CONTROLLED STUDY; EMBRYONIC STEM CELL; FACIAL NERVE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MIXED INFECTION; MOTONEURON; NERVE CELL CULTURE; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; FUS; PROTEASOME; TDP-43;

ADENOVIRIDAE; ANIMALS; ASTROCYTES; CELLS, CULTURED; DNA-BINDING PROTEINS; EMBRYONIC STEM CELLS; HEK293 CELLS; HUMANS; INCLUSION BODIES; MALE; MICE; MOTOR NEURONS; OLIGODENDROGLIA; RATS; RATS, INBRED F344; RATS, MUTANT STRAINS; RNA, SMALL INTERFERING; RNA-BINDING PROTEIN FUS;

EID: 84892813933     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12058     Document Type: Article

References (73)

1. Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 2011; 7: 603-615.
2. Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 2013; 14: 248-264.
3. Turner MR, Hardiman O, Benatar M etal. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol 2013; 12: 310-322.
4. Arai T, Hasegawa M, Akiyama H etal. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602-611.
5. Neumann M, Sampathu DM, Kwong LK etal. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-133.
6. Chen-Plotkin AS, Lee VM, Trojanowski JQ. TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol 2010; 6: 211-220.
7. Lee EB, Lee VM, Trojanowski JQ. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci 2012; 13: 38-50.
8. Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 2013; 125: 777-794.
9. Lagier-Tourenne C, Cleveland DW. Rethinking ALS: the FUS about TDP-43. Cell 2009; 136: 1001-1004.
10. Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 2010; 19: R46-R64.
11. Da Cruz S, Cleveland DW. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr Opin Neurobiol 2011; 21: 904-919.
12. Thomas M, Alegre-Abarrategui J, Wade-Martins R. RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum. Brain 2013; 136: 1345-1366.
13. Bendotti C, Marino M, Cheroni C etal. Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response. Prog Neurobiol 2012; 97: 101-126.
14. Banerjee R, Beal MF, Thomas B. Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci 2010; 33: 541-549.
15. Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 2010; 13: 805-811.
16. Bedford L, Hay D, Devoy A etal. Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies. J Neurosci 2008; 28: 8189-8198.
17. Komatsu M, Waguri S, Chiba T etal. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006; 441: 880-884.
18. Hara T, Nakamura K, Matsui M etal. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441: 885-889.
19. Filimonenko M, Stuffers S, Raiborg C etal. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J Cell Biol 2007; 179: 485-500.
20. Igaz LM, Kwong LK, Chen-Plotkin A etal. Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J Biol Chem 2009; 284: 8516-8524.
21. Kanegae Y, Takamori K, Sato Y, Lee G, Nakai M, Saito I. Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase. Gene 1996; 181: 207-212.
22. Miyake S, Makimura M, Kanegae Y etal. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci U S A 1996; 93: 1320-1324.
23. Watabe K, Ohashi T, Sakamoto T etal. Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor. J Neurosci Res 2000; 60: 511-519.
24. Sakamoto T, Kawazoe Y, Shen JS etal. Adenoviral gene transfer of GDNF, BDNF and TGFβ2, but not CNTF, cardiotrophin-1 or IGF1, protects injured adult motoneurons after facial nerve avulsion. J Neurosci Res 2003; 72: 54-64.
25. Watabe K, Ida H, Uehara K etal. Establishment and characterization of immortalized Schwann cells from murine model of Niemann-Pick disease type C (spm/spm). J Peripher Nerv Syst 2001; 6: 85-94.
26. Palmer TD, Markakis EA, Willhoite AR, Safar F, Gage FH. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J Neurosci 1999; 19: 8487-8497.
27. Wichterle H, Lieberam I, Porter JA, Jessell TM. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002; 110: 385-397.
28. Wada T, Honda M, Minami I etal. Highly efficient differentiation and enrichment of spinal motor neurons derived from human and monkey embryonic stem cells. PLoS ONE 2009; 4: e6722.
29. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 2007; 10: 608-614.
30. Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem 2008; 283: 13302-13309.
31. Nonaka T, Arai T, Buratti E, Baralle FE, Akiyama H, Hasegawa M. Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett 2009; 583: 394-400.
32. Nonaka T, Kametani F, Arai T, Akiyama H, Hasegawa M. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum Mol Genet 2009; 18: 3353-3364.
33. Zhang YJ, Xu YF, Cook C etal. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci U S A 2009; 106: 7607-7612.
34. Urushitani M, Sato T, Bamba H, Hisa Y, Tooyama I. Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43. J Neurosci Res 2010; 88: 784-797.
35. Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 2010; 30: 639-649.
36. Ling SC, Albuquerque CP, Han JS etal. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci U S A 2010; 107: 13318-13323.
37. Duan W, Li X, Shi J, Guo Y, Li Z, Li C. Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell. Neuroscience 2010; 169: 1621-1629.
38. Yang C, Tan W, Whittle C etal. The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism. PLoS ONE 2010; 5: e15878.
39. van Eersel J, Ke YD, Gladbach A etal. Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons. PLoS ONE 2011; 6: e22850.
40. Dormann D, Rodde R, Edbauer D etal. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 2010; 29: 2841-2857.
41. Dormann D, Haass C. TDP-43 and FUS: a nuclear affair. Trends Neurosci 2011; 34: 339-348.
42. Dewey CM, Cenik B, Sephton CF, Johnson BA, Herz J, Yu G. TDP-43 aggregation in neurodegeneration: are stress granules the key? Brain Res 2012; 1462: 16-25.
43. Li YR, King OD, Shorter J, Gitler AD. Stress granules as crucibles of ALS pathogenesis. J Cell Biol 2013; 201: 361-372.
44. Bentmann E, Haass C, Dormann D. Stress granules in neurodegeneration - lessons learnt from TAR DNA binding protein of 43kDa and fused in sarcoma. FEBS J 2013. doi: 10.1111/febs.12287
45. Mazroui R, Di Marco S, Kaufman RJ, Gallouzi IE. Inhibition of the ubiquitin-proteasome system induces stress granule formation. Mol Biol Cell 2007; 18: 2603-2618.
46. Lin WL, Dickson DW. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol 2008; 116: 205-213.
47. Shan X, Chiang PM, Price DL, Wong PC. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc Natl Acad Sci U S A 2010; 107: 16325-16330.
48. Xu YF, Gendron TF, Zhang YJ etal. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci 2010; 30: 10851-10859.
49. Xu YF, Zhang YJ, Lin WL etal. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice. Mol Neurodegener 2011; 6: 73.
50. Gendron TF, Petrucelli L. Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegeneration. J Mol Neurosci 2011; 45: 486-499.
51. Huang C, Zhou H, Tong J etal. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. PLoS Genet 2011; 7: e1002011.
52. Tsao W, Jeong YH, Lin S etal. Rodent models of TDP-43: recent advances. Brain Res 2012; 1462: 26-39.
53. Lanson NA Jr, Pandey UB. FUS-related proteinopathies: lessons from animal models. Brain Res 2012; 1462: 44-60.
54. Mitchell JC, McGoldrick P, Vance C etal. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol 2013; 125: 273-288.
55. Janssens J, Wils H, Kleinberger G etal. Overexpression of ALS-associated p.M337V human TDP-43 in mice worsens disease features compared to wild-type human TDP-43 mice. Mol Neurobiol 2013; 48: 22-35.
56. Huang C, Xia PY, Zhou H. Sustained expression of TDP-43 and FUS in motor neurons in rodent's lifetime. Int J Biol Sci 2010; 6: 396-406.
57. Geser F, Robinson JL, Malunda JA etal. Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch Neurol 2010; 67: 1238-1250.
58. Arnold SJ, Dugger BN, Beach TG. TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies. Acta Neuropathol 2013; 126: 51-57.
59. Li XJ, Li S. Proteasomal dysfunction in aging and Huntington disease. Neurobiol Dis 2011; 43: 4-8.
60. Cuervo AM. Autophagy and aging: keeping that old broom working. Trends Genet 2008; 24: 604-612.
61. Kabashi E, Agar JN, Strong MJ, Durham HD. Impaired proteasome function in sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2012; 13: 367-371.
62. Tashiro Y, Urushitani M, Inoue H etal. Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis. J Biol Chem 2012; 287: 42984-42994.
63. Wang IF, Guo BS, Liu YC etal. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci U S A 2012; 109: 15024-15029.
64. Tatom JB, Wang DB, Dayton RD etal. Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression. Mol Ther 2009; 17: 607-613.
65. Wang DB, Dayton RD, Henning PP etal. Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed. Mol Ther 2010; 18: 2064-2074.
66. Uchida A, Sasaguri H, Kimura N etal. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43. Brain 2012; 135: 833-846.
67. Verbeeck C, Deng Q, Dejesus-Hernandez M etal. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis. Mol Neurodegener 2012; 7: 53.
68. Dayton RD, Gitcho MA, Orchard EA etal. Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis. Mol Ther 2013; 21: 1324-1334.
69. Furukawa Y, Kaneko K, Watanabe S, Yamanaka K, Nukina N. A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J Biol Chem 2011; 286: 18664-18672.
70. Polymenidou M, Cleveland DW. The seeds of neurodegeneration: prion-like spreading in ALS. Cell 2011; 147: 498-508.
71. King OD, Gitler AD, Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 2012; 1462: 61-80.
72. Nonaka T, Masuda-Suzukake M, Arai T etal. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep 2013; 4: 124-134.
73. Furukawa Y, Kaneko K, Watanabe S, Yamanaka K, Nukina N. Intracellular seeded aggregation of mutant Cu, Zn-superoxide dismutase associated with amyotrophic lateral sclerosis. FEBS Lett 2013. doi: 10.1016/j.febslet.2013.06.046